GMP SYNTHESIS OF BULK DRUG TESTING
$477,283N01FY2009DANIH
Norac, Inc., Azusa CA
Investigators
Abstract
This contract shall provide the manufature of bulk drug substances under GMP. These bulk drug substances will support NIDA clinical Trials.
View original record on NIH RePORTER →